The Patent Finder
OB

Optiscan Biomedical Corporation

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesPatent listSources & methods

0 patents currently held, every record listed here

8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
20 more records may belong here and await a decision; they are not counted.

This portfolio holds none of the 8 US patents in force on its record. from the record

Of the 8 now held by other companies, 8 name Insulet Corporation as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
none
Next term end

When these terms end

Each bar runs from grant to computed term end. 2011 to 2032.
US 9,289,169 Analyte Monitoring Systems and Methods May 19, 2028
US 10,677,688 Fluid Injection and Safety System May 19, 2028
US 7,972,296 Fluid Component Analysis System and Method for Glucose Monitoring and Control Oct 10, 2028
US 9,632,013 Fluid Injection and Safety System Sep 3, 2029
US 9,302,045 Fluid Component Analysis System and Method for Glucose Monitoring and Control Jan 28, 2030
US 8,417,311 Fluid Component Analysis System and Method for Glucose Monitoring and Control Jun 18, 2030
US 8,412,293 Systems And Methods For Determining Physiological Parameters Using Measured Analyte Values Aug 2, 2031
US 8,470,241 Fluid Injection and Safety System Feb 9, 2032
201520192023202720312032
Every computed term in this portfolio is shown above.Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
None of the currently held patents qualifies as notable.

Formerly held, still cited

Notable
Cited by 333 later US patents, top 1% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030.
Ends Jun 2030 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 16, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first.
Also on record: 8 patents in force now held by others · 54 patents ended · 69 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
4 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed
11 computed term dates come from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited